Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.09 by 55.56 percent. This is a 100 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $22.459 million which beat the analyst consensus estimate of $20.474 million by 9.70 percent. This is a 117.54 percent increase over sales of $10.324 million the same period last year.